U.S. markets close in 1 hour 38 minutes
  • S&P 500

    3,848.86
    +49.95 (+1.31%)
     
  • Dow 30

    31,138.90
    +208.38 (+0.67%)
     
  • Nasdaq

    13,446.55
    +249.37 (+1.89%)
     
  • Russell 2000

    2,157.06
    +5.92 (+0.28%)
     
  • Crude Oil

    53.26
    +0.28 (+0.53%)
     
  • Gold

    1,867.60
    +27.40 (+1.49%)
     
  • Silver

    25.84
    +0.52 (+2.07%)
     
  • EUR/USD

    1.2109
    -0.0024 (-0.19%)
     
  • 10-Yr Bond

    1.0890
    -0.0030 (-0.27%)
     
  • GBP/USD

    1.3644
    +0.0010 (+0.08%)
     
  • USD/JPY

    103.5780
    -0.3140 (-0.30%)
     
  • BTC-USD

    35,115.31
    +715.34 (+2.08%)
     
  • CMC Crypto 200

    694.75
    -5.86 (-0.84%)
     
  • FTSE 100

    6,740.39
    +27.44 (+0.41%)
     
  • Nikkei 225

    28,523.26
    -110.20 (-0.38%)
     

Alkermes to Present at the 39th Annual J.P. Morgan Healthcare Conference

·1 min read

DUBLIN, Jan. 6, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 39th Annual J.P. Morgan Healthcare Conference. The presentation will take place virtually on Wednesday, Jan. 13, 2021 at 10:00 a.m. EST (3:00 p.m. GMT), followed by a question and answer session. The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

Alkermes plc Logo (PRNewsfoto/Alkermes plc)
Alkermes plc Logo (PRNewsfoto/Alkermes plc)
Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-to-present-at-the-39th-annual-jp-morgan-healthcare-conference-301201851.html

SOURCE Alkermes plc